HIND
Vyome Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.22
−0.45%Margins
Gross margin
46.5%
EBITDA margin
-8886.4%
EBIT margin
-3250.3%
Net margin
-8716.8%
FCF margin
404.3%
-187.0%
Return on equity
-123.2%
Return on assets
-69.5%
Return on invested capital
0.01x
Asset turnover
$524.5K
Cash from operations
$1.12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026